Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Susan G. Komen Chicago Commits $787,500 in 2020 to Decrease Breast Cancer Mortality Gap, Increase Access to Care for Communities of Greatest Need

Chicago's leading breast cancer organization makes groundbreaking investment in its mission through funding The Chicago Health Equity Initiative, Komen Chicago Treatment Assistance Program and Local Community Grant Programming


News provided by

Susan G. Komen Chicago

Oct 29, 2020, 08:05 ET

Share this article

Share toX

Share this article

Share toX

Susan G. Komen Chicago
Susan G. Komen Chicago

CHICAGO, Oct. 29, 2020 /PRNewswire-PRWeb/ -- In recognition of October's Breast Cancer Awareness Month, Susan G. Komen Chicago is proud to announce a substantial commitment to initiating change in healthcare access for all Chicagoland women. In 2020 alone, the organization has committed $787,500 to advancing health equity for all and demolishing the racial disparities gap -- a 68 percent increase in funding year over year.

"Although we've seen the breast cancer mortality rate decline in recent years, these benefits have been disproportionate and there is still evidence of a mortality gap between black and white patients nationally, with African American women 42 percent more likely to die from the disease," said Dr. Tiosha Bailey, executive director of Komen Chicago. Also, in Chicago, African American women are 40 percent more likely to die from breast cancer than white women; for African American women aged 40 and under, the disparity increases to 157 percent.

Komen Chicago’s ability to commit this funding, while in the midst of a pandemic, is monumental for our community.

Post this

"It is imperative to offer genetic counseling and testing to this demographic, especially here in Chicago, which is why Komen Chicago's ability to commit this funding, while in the midst of a pandemic, is monumental for our community," added Bailey.

Komen Chicago's investment into the local community will help transform direct services and healthcare systems. Of the total investment:

  • $400,000 is committed to Chicago Health Equity Initiative (CHEI), a cohort of Chicago-area medical leaders who support healthcare systems' transformation. In leading this cohort's formation, Komen Chicago is evolving from exclusively funding breast health services to working collaboratively with a broad spectrum of partners to implement measurable and sustainable solutions that improve care and decrease costs. This is the first funding investment of its kind for Komen Chicago and the largest community investment made in the affiliate's history.
  • $350,000 is funding local community grant programming that provides direct patient services for navigation, screening/diagnostic, and survivorship support programs in Komen Chicago's five-county service area, including a strategic investment in McHenry County to help target the late stage breast cancer diagnosis rate identified in this area.
  • $37,5000 supports the Komen Chicago Treatment Assistance Program that provides patients who are in treatment with financial and psychosocial assistance programs to help reduce barriers and increase survival rates.

Komen Chicago has convened the following partners for CHEI: three Federally Qualified Health Centers (Access Community Health Network, Erie Family Health Centers and Friend Family Health Center), six major health systems in Cook County (Cook County Health and Hospital System, University of Chicago Medicine, University of Illinois Cancer Center, Rush University Medical Center, Northwestern University Cancer Center and Sinai Health System), the Illinois Medical District, American Cancer Society and Chicago Department of Public Health. The CHEI implementation plan is currently being developed, with services scheduled to begin in 2021.

The University of Illinois (UI) Cancer Center at UI Health has been designated as the Komen Chicago Lead in the CHEI consortium. The UI Cancer Center's community-facing mission and commitment to promote health equity and eradicate cancer disparities in Chicago communities and beyond make it an ideal lead partner.

"Not only will CHEI work tirelessly to decrease health disparities across our city, but we will be firm advocates for education and access for all by raising awareness of these key initiatives to our community members and neighbors," said CHEI director, Dr. John H. Stewart from UI Cancer Center.

"We are so proud to bring together this revolutionary consortium of Chicago's top medical leaders to create actionable change within the systems of our current healthcare structure," said Dr. Suzet McKinney, president of Komen Chicago's Board of Directors and CHEI partner representing the Illinois Medical District. "We have three key goals at hand -- decrease breast mortality disparities across Chicagoland, reduce the detection-to-diagnosis interval, and increase the number of high-risk women under age 40 who receive genetic screening."

"Through CHEI, we will work to implement genetic counseling and testing in the primary care setting to increase early detection of breast cancer," said Dr. Olufunmilayo I. Olopade, Director of the Center for Clinical Cancer Genetics & Global Health and Medical Oncologist at the University of Chicago Medical Center. "The sooner we can detect signs of breast cancer, the sooner we can begin treatment and lower breast cancer mortality across the board."

Since 1997, Komen Chicago has invested over $18.5 million in local community grants and $6 million in breakthrough research. The organization has reaffirmed its continued mission of investing 100 percent of net proceeds back into local community grantmaking and research initiatives for more than two decades. In the coming months, Susan G. Komen's national headquarters is moving forward with plans to consolidate all Komen affiliates into One Komen.

"As a result of the current climate, changes must occur to maintain Komen's national commitment to preventing and curing breast cancer. Komen Chicago is working with the national team to ensure a strong local impact remains for Chicago-area women," added Bailey.

For more information on Komen Chicago, its programs and the Chicago Health Equity Initiative, please visit http://www.komenchicago.org.

About Komen Chicago
Susan G. Komen's promise is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer. Komen Chicago donates 100 percent of net funds raised to community grants and global research. Komen Chicago's priorities include making sure everyone has access to quality healthcare options, fighting to ensure fewer people die from metastatic breast cancer and shining a light on the importance of early detection. For more information visit komenchicago.org.

SOURCE Susan G. Komen Chicago

Related Links

https://komenchicago.org/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.